Cargando…
Triptolide suppresses the growth and metastasis of non-small cell lung cancer by inhibiting β-catenin-mediated epithelial–mesenchymal transition
Non-small cell lung cancer (NSCLC) is characterized by a high incidence of metastasis and poor survival. As epithelial–mesenchymal transition (EMT) is well recognized as a major factor initiating tumor metastasis, developing EMT inhibitor could be a feasible treatment for metastatic NSCLC. Recent st...
Autores principales: | Deng, Qiu-di, Lei, Xue-ping, Zhong, Yi-hang, Chen, Min-shan, Ke, Yuan-yu, Li, Zhan, Chen, Jing, Huang, Li-juan, Zhang, Yu, Liang, Lu, Lin, Zhong-xiao, Liu, Qing, Li, Song-pei, Yu, Xi-yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379262/ https://www.ncbi.nlm.nih.gov/pubmed/33893396 http://dx.doi.org/10.1038/s41401-021-00657-w |
Ejemplares similares
-
GATA6 promotes epithelial-mesenchymal transition and metastasis through MUC1/β-catenin pathway in cholangiocarcinoma
por: Deng, Xiang, et al.
Publicado: (2020) -
MiR-195 suppresses the metastasis and epithelial–mesenchymal transition of hepatocellular carcinoma by inhibiting YAP
por: Yu, Shuo, et al.
Publicado: (2017) -
Triptolide reverses epithelial-mesenchymal transition in glioma cells via inducing autophagy
por: Lai, Minfang, et al.
Publicado: (2021) -
CCR9 initiates epithelial–mesenchymal transition by activating Wnt/β-catenin pathways to promote osteosarcoma metastasis
por: Kong, Haoran, et al.
Publicado: (2021) -
Triptolide inhibits epithelial-mesenchymal transition and induces apoptosis in gefitinib-resistant lung cancer cells
por: Li, Fangqiong, et al.
Publicado: (2020)